Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: A Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma
A clinical trial assessing Adcetris (brentuximab vedotin) in adults with Hodgkin lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma. [Phase 1]
A Phase 1 clinical trial led by Murdoch Children's Research Institute is investigating changes in metabolism phenotype in paediatric, adoles…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors. [NA]
This clinical trial update describes a post-treatment program to identify and manage complications related to oncology or hematology treatme…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events
A completed Stanford-led clinical trial evaluating wearable sensors and molecular omics approaches to detect and mitigate adverse events dur…
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: Phase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCL [Phase 2]
A Phase 2 study evaluating AFM13 in combination with AB-101 for relapsed or refractory Hodgkin lymphoma and CD30+ peripheral T-cell lymphoma…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma [Phase 1]
Phase 1 trial of MT-601 in relapsed/refractory lymphoma shows safety and preliminary efficacy signals in both non-Hodgkin lymphoma and Hodgk…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: PD-1 Inhibitors Maintenance for cHL Post-autoHCT [Phase 2]
Phase 2 trial assessing maintenance PD-1 inhibitors in classical Hodgkin lymphoma after autologous stem cell transplant; currently recruitin…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Breast Cancer Risk Investigation in Grown-up Hodgkin Lymphoma Patients Treated With MBVD. Multicenter Retrospective Study on ≥200 Adult Female HL Patients Treated With ≥1 MBVD Cycle (NPLD, Bleomycin, Vinblastine, Dacarbazine). It Investigates Breast Cancer Incidence Post-treatment.
This multicenter retrospective study evaluates the incidence of breast cancer in adult female Hodgkin lymphoma survivors treated with MBVD (…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Early Detection of Patients at Risk of Developing Anthracycline Cardiotoxicity With TEP/CT -FDG [NA]
A clinical trial investigating early detection of anthracycline cardiotoxicity risk in lymphoma patients using TEP/CT-FDG imaging, currently…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study [Phase 2]
A single-arm Phase II trial in advanced Hodgkin lymphoma evaluating a very early PET-response-guided targeted therapy; results have been pos…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion [Phase 2]
A Phase 2 clinical trial evaluating allogeneic stem cell transplantation with alpha/beta T cell and CD19+ B cell depletion for malignant and…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: FIL Study on ABVD DD-DI as Upfront Therapy in HL. [Phase 3]
Phase 3 clinical trial update on the FIL study evaluating ABVD DD-DI as upfront therapy for Hodgkin lymphoma. The trial status is completed.
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma [Phase 3]
Ongoing Phase 3 clinical trial evaluating combination chemotherapy with or without radiation therapy in Hodgkin lymphoma, sponsored by the E…
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma [Phase 3]
A Phase 3 clinical trial compared two combination chemotherapy regimens in patients with stage III or stage IV Hodgkin lymphoma. The study s…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma [Phase 3]
Phase 3 trial evaluating radiation therapy with or without combination chemotherapy in previously untreated stage I-II Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease [Phase 3]
A Phase 3 trial compares radiotherapy after chemotherapy versus no radiotherapy in patients with Stage III/IV Hodgkin lymphoma to determine …
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30) [Phase 1]
Phase 1 clinical trial of CD30-directed CAR T cells for relapsed CD30-expressing Hodgkin lymphoma and non-Hodgkin lymphoma is currently recr…
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Haplo Peripheral Blood Sct In GVHD Prevention [Phase 1]
Phase 1 trial update reporting the completion of a haploidentical peripheral blood stem cell transplantation approach for the prevention of …
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling [Phase 1]
Phase 1 clinical trial evaluating ex vivo drug sensitivity testing and multi-omics profiling in pediatric cancers. Recruitment is ongoing ac…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma [NA]
This clinical trial update covers a study of Brentuximab Vedotin in combination with AVD chemotherapy for newly diagnosed early-stage, unfav…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant [Phase 2]
A Phase II randomized trial evaluating hyperbaric oxygen to improve engraftment after umbilical cord blood stem cell transplantation in pati…
-
CLINICAL_TRIALS trial_result · 2025-07-04Clinical Trial Update: UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep [Phase 2]
Phase 2 clinical trial evaluating non-myeloablative preparative regimens followed by umbilical cord blood transplantation for various hemato…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Tumor Associated Antigen Specific T Cells (TAA-T) With PD1 Inhibitor for Lymphoma [Phase 1]
Phase 1 clinical trial investigating tumor-associated antigen-specific T cells (TAA-T) in combination with a PD-1 inhibitor for Hodgkin lymp…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial evaluating pembrolizumab plus BEAM conditioning with autologous stem cell transplant for relapsed Hodgkin lymphoma. T…
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Avelumab With Valproic Acid in Virus-associated Cancer [Phase 2]
Phase 2 trial evaluating the PD-L1 inhibitor avelumab in combination with valproic acid for virus-associated cancers has completed; the upda…